Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholinergic REM sleep induction in atypical depression.

S Wager1, D Robinson, R Goetz

  • 1Department of Therapeutics, New York State Psychiatric Institute, New York, NY 10032.

Biological Psychiatry
|February 15, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determination of amylose/particulate relationship in hydroxyethylstarch.

PDA journal of pharmaceutical science and technology·2001
Same author

Macrosomatognosia and microsomatognosia in migraine art.

Acta neurologica Scandinavica·2000
Same author

Are microorganisms more effective than plants at competing for nitrogen?

Trends in plant science·2000
Same author

Retraining of a competitive master athlete following traumatic injury: a case study.

Medicine and science in sports and exercise·2000
Same author

Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment.

Toxicologic pathology·2000
Same author

Inflammatory reactions associated with a calcium sulfate bone substitute.

Annals of transplantation·2000

A study found that arecoline REM induction test results in atypical depression patients differ based on anxiety history. Those without anxiety showed heightened central cholinergic sensitivity, suggesting a potential biomarker for specific depression subtypes.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Sleep Medicine

Background:

  • Atypical depression is a subtype of depression with distinct clinical features.
  • Central cholinergic system function is implicated in mood disorders.
  • The arecoline REM induction test measures central cholinergic sensitivity.

Purpose of the Study:

  • To investigate central cholinergic sensitivity in patients with atypical depression using the arecoline REM induction test.
  • To determine if anxiety symptoms influence the cholinergic response in atypical depression.
  • To compare the findings in atypical depression with other affective disorders.

Main Methods:

  • 10 patients with atypical depression underwent the arecoline REM induction test.
  • REM sleep latency was measured after arecoline administration compared to placebo.

Related Experiment Videos

  • Patients were subgrouped based on the presence or absence of anxiety symptoms and panic attacks.

    • Main Results:

    • Arecoline significantly shortened REM sleep latency in atypical depressives compared to placebo.
    • Atypical depressives without anxiety symptoms exhibited a more rapid REM induction response.
    • This rapid response in non-anxious atypical depressives was comparable to that seen in endogenous depressives and euthymic bipolars, groups known to have cholinergic supersensitivity.

    Conclusions:

    • The arecoline REM induction test can differentiate atypical depressives based on anxiety history.
    • Cholinergic supersensitivity is present in atypical depressives who do not have anxiety symptoms.
    • These findings suggest a potential neurobiological distinction within atypical depression subtypes.